FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
0.24 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15405 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
7 |
|
141.79 |
% |
9.33 |
24.68 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54228 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
150.56 |
% |
11.05 |
31.25 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54098 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
8 |
|
149.3 |
breaths/min |
9.53 |
26.97 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17121 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
11 |
|
117.0 |
% |
9.15 |
30.35 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53766 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
8 |
|
101.3 |
breaths/min |
4.15 |
11.72 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18418 |
381 |
FHH-Chr 18BN/Mcwi |
serum total cholesterol level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
10 |
|
75.4 |
mg/dl |
1.38 |
4.38 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37105 |
401 |
FHH-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
|
424.91 |
mg/d |
55.78 |
167.35 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52111 |
482 |
FHH-Chr 18BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
9 |
|
48.46 |
mg/d |
29.49 |
88.47 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52406 |
482 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
0.43 |
mg/dl |
0.05 |
0.14 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52260 |
482 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
5 |
|
125.97 |
mmHg |
6.67 |
14.92 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13500 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
0.23 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17992 |
381 |
FHH-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
7.46 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20639 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
7 |
|
154.38 |
breaths/min |
4.8 |
12.7 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16919 |
381 |
FHH-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
9 |
|
377.11 |
U/l |
24.44 |
73.33 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37487 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
126.12 |
% |
10.63 |
35.25 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18553 |
381 |
FHH-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
10 |
|
5.51 |
g/dl |
0.07 |
0.21 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37238 |
401 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
388.29 |
beats/min |
19.22 |
54.36 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17519 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
10 |
|
403.49 |
beats/min |
13.9 |
43.95 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17522 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
8 |
|
121.98 |
breaths/min |
3.25 |
9.19 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18273 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
11 |
|
123.21 |
breaths/min |
5.35 |
17.75 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18275 |
381 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
5.98 |
mmHg |
0.18 |
0.48 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49185 |
461 |
FHH-Chr 18BN/Mcwi |
absolute change in body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
0.46 |
degrees C |
0.3 |
0.9 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20317 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
-0.37 |
degrees C |
0.29 |
0.99 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20319 |
381 |
FHH-Chr 18BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
10 |
|
142.5 |
mmol/l |
0.34 |
1.08 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36530 |
401 |
FHH-Chr 18BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
1116.67 |
s |
46.15 |
138.44 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50237 |
461 |
FHH-Chr 18BN/Mcwi |
serum albumin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
10 |
|
3.82 |
g/dl |
0.04 |
0.14 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42241 |
401 |
FHH-Chr 18BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
10 |
|
0.37 |
x 1000 cells/ul |
0.04 |
0.13 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38936 |
401 |
FHH-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
10 |
|
87.8 |
U/l |
3.21 |
10.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42780 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
18.78 |
pg |
0.07 |
0.22 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42555 |
401 |
FHH-Chr 18BN/Mcwi |
serum sodium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
10 |
|
143.3 |
mmol/l |
0.63 |
2.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39396 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
11 |
|
117.53 |
% |
8.71 |
28.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54339 |
381 |
FHH-Chr 18BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
10 |
|
27.1 |
mmol/l |
0.6 |
1.91 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43030 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
157.51 |
% |
3.5 |
9.25 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54434 |
381 |
FHH-Chr 18BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
10 |
|
0.08 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42923 |
401 |
FHH-Chr 18BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
9 |
|
0.24 |
x 1000 cells/ul |
0.07 |
0.22 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40331 |
401 |
FHH-Chr 18BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
10 |
|
52.82 |
% |
0.71 |
2.24 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59265 |
526 |
FHH-Chr 18BN/Mcwi |
total white blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
10 |
|
6.36 |
x 1000 cells/ul |
0.54 |
1.7 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40936 |
401 |
FHH-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.05 |
g/kg |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59494 |
526 |
FHH-Chr 18BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.15 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59557 |
526 |
FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
10 |
|
16.81 |
g/dl |
0.23 |
0.72 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37976 |
401 |
FHH-Chr 18BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
10 |
|
53.8 |
U/l |
4.24 |
13.4 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37747 |
401 |
FHH-Chr 18BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
10 |
|
134.5 |
mg/dl |
3.68 |
11.63 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41234 |
401 |
FHH-Chr 18BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
10 |
|
80.6 |
mg/dl |
1.59 |
5.04 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38473 |
401 |
FHH-Chr 18BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
10 |
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41444 |
401 |
FHH-Chr 18BN/Mcwi |
serum total bilirubin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77 days-91 days |
10 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41878 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
43.14 |
% |
2.38 |
6.28 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48535 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
26.85 |
ml/min/kg |
1.84 |
5.22 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57808 |
526 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
-8.38 |
null |
0.05 |
0.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55306 |
522 |
FHH-Chr 18BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
0.37 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16483 |
381 |
FHH-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.21 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57941 |
526 |
FHH-Chr 18BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.45 |
null |
0.03 |
0.07 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58121 |
526 |
FHH-Chr 18BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
1.26 |
E-7mole |
0.13 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55925 |
522 |
FHH-Chr 18BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
1.47 |
g/mg |
0.12 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55819 |
522 |
FHH-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
84.33 |
% |
3.7 |
11.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54808 |
522 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
27.56 |
ml/min/kg |
1.33 |
4.19 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58663 |
526 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
-7.7 |
null |
0.17 |
0.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56133 |
522 |
FHH-Chr 18BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
8 |
|
0.04 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58497 |
526 |
FHH-Chr 18BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
1.15 |
E-7mole |
0.33 |
1.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56548 |
522 |
FHH-Chr 18BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.13 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59925 |
526 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-7.05 |
null |
0.1 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56943 |
522 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-6.94 |
null |
0.1 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56946 |
522 |
FHH-Chr 18BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
0.37 |
ml |
0.03 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17378 |
381 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
8 |
|
38.59 |
mmHg |
1.27 |
3.58 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16086 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
10 |
|
164.5 |
g |
6.1 |
19.3 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47841 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
5.32 |
mmHg |
0.23 |
0.61 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47207 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
54.75 |
mmHg |
5.1 |
15.3 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47919 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
8 |
|
126.26 |
% |
11.14 |
31.49 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53762 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
214.51 |
beats/min |
7.9 |
23.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48955 |
461 |
FHH-Chr 18BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82 days-99 days |
8 |
|
-7.44 |
mmHg |
0.71 |
2.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19651 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82 days-99 days |
9 |
|
229.6 |
g |
5.6 |
16.9 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17825 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
0.25 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15407 |
381 |
FHH-Chr 18BN/Mcwi |
serum total cholesterol level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77 days-91 days |
10 |
|
64.4 |
mg/dl |
1.28 |
4.06 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37107 |
401 |
FHH-Chr 18BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
9 |
|
4.49 |
x 1000 cells/ul |
0.74 |
2.23 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36906 |
401 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
female |
82 days-99 days |
8 |
|
31.15 |
mmHg |
1.21 |
3.43 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17259 |
381 |
FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
8 |
|
36.92 |
degrees C |
0.4 |
1.12 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19079 |
381 |
FHH-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
9 |
|
64.77 |
mg/d |
14.16 |
42.49 |
automated urine total protein analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52114 |
482 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
2 |
post-ischemic value/pre-ischemic value x 100% |
70.46 |
% |
4.52 |
6.39 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46327 |
461 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
221.71 |
beats/min |
17.32 |
51.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45158 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
48.66 |
mmHg |
6.9 |
20.71 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45280 |
461 |
FHH-Chr 18BN/Mcwi |
plasma anion gap |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
10 |
|
16.7 |
mmol/l |
0.83 |
2.63 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38271 |
401 |
FHH-Chr 18BN/Mcwi |
serum glucose level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
10 |
|
151.1 |
mg/dl |
2.39 |
7.55 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38538 |
401 |
FHH-Chr 18BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
6 |
|
59.82 |
ml/min/kg |
4.54 |
11.13 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58266 |
526 |
FHH-Chr 18BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
9 |
|
22.16 |
% |
6.2 |
18.59 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49406 |
461 |
FHH-Chr 18BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
897.8 |
s |
39.67 |
125.44 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50129 |
461 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
263.05 |
beats/min |
5.53 |
16.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47590 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
6 |
|
0.47 |
null |
0.01 |
0.03 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59809 |
526 |
FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77 days-91 days |
9 |
|
43.63 |
% |
1.53 |
4.58 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57524 |
526 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
20.91 |
ml/min |
1.04 |
2.95 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16157 |
381 |
FHH-Chr 18BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
9 |
|
8.44 |
mg/dl |
0.28 |
0.84 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37864 |
401 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
15.12 |
ml/min/kg |
0.82 |
2.59 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
60034 |
526 |
FHH-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
9 |
|
11.86 |
mEq/d |
2.45 |
7.36 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52797 |
482 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
109.35 |
% |
8.6 |
24.33 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53995 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
0.03 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19800 |
381 |
FHH-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77 days-91 days |
10 |
|
426.2 |
U/l |
8.94 |
28.27 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36387 |
401 |
FHH-Chr 18BN/Mcwi |
serum total protein level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77 days-91 days |
10 |
|
4.98 |
g/dl |
0.09 |
0.27 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36972 |
401 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
53.18 |
ml/min |
2.53 |
7.15 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14510 |
381 |
FHH-Chr 18BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
8 |
|
36.63 |
degrees C |
0.27 |
0.77 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13569 |
381 |
FHH-Chr 18BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
10 |
|
10.11 |
mg/dl |
0.12 |
0.38 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36799 |
401 |
FHH-Chr 18BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
0.7 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49070 |
461 |
FHH-Chr 18BN/Mcwi |
absolute change in partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
-43.07 |
mmHg |
2.52 |
7.13 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19479 |
381 |
FHH-Chr 18BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
1061.11 |
s |
41.12 |
123.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50235 |
461 |
FHH-Chr 18BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
9 |
|
908.33 |
s |
39.95 |
119.85 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49309 |
461 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
10 |
|
0.17 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42686 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
8 |
|
122.0 |
% |
6.72 |
19.0 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54335 |
381 |
FHH-Chr 18BN/Mcwi |
blood neutrophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
10 |
|
1.05 |
x 1000 cells/ul |
0.08 |
0.25 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43232 |
401 |
FHH-Chr 18BN/Mcwi |
blood monocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
10 |
|
0.36 |
x 1000 cells/ul |
0.06 |
0.18 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39684 |
401 |
FHH-Chr 18BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77 days-91 days |
10 |
|
4.08 |
x 1000 cells/ul |
0.34 |
1.07 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39925 |
401 |
FHH-Chr 18BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
9 |
|
103.89 |
mmol/l |
0.35 |
1.05 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40043 |
401 |
FHH-Chr 18BN/Mcwi |
serum alanine aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
10 |
|
62.7 |
U/l |
1.56 |
4.92 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40722 |
401 |
FHH-Chr 18BN/Mcwi |
serum globulin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
10 |
|
1.25 |
g/dl |
0.05 |
0.14 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40560 |
401 |
FHH-Chr 18BN/Mcwi |
serum urea nitrogen level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
10 |
|
20.7 |
mg/dl |
1.0 |
3.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40836 |
401 |
FHH-Chr 18BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
10 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59398 |
526 |
FHH-Chr 18BN/Mcwi |
serum potassium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
10 |
|
4.83 |
mmol/l |
0.22 |
0.68 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38074 |
401 |
FHH-Chr 18BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77 days-91 days |
9 |
|
93.0 |
mg/dl |
2.67 |
8.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38470 |
401 |
FHH-Chr 18BN/Mcwi |
blood lymphocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77 days-91 days |
10 |
|
6.61 |
x 1000 cells/ul |
0.58 |
1.83 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41511 |
401 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
55.82 |
mmHg |
3.46 |
10.38 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46425 |
461 |
FHH-Chr 18BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
1.05 |
g/mg |
0.15 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57365 |
522 |
FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
36.97 |
degrees C |
0.22 |
0.77 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16822 |
381 |
FHH-Chr 18BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
1.02 |
g/mg |
0.09 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55816 |
522 |
FHH-Chr 18BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
1.62 |
E-7mole |
0.25 |
0.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55922 |
522 |
FHH-Chr 18BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
5.31 |
g/kg |
0.23 |
0.72 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47019 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
6.91 |
ml/min/g |
0.73 |
2.2 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44728 |
461 |
FHH-Chr 18BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
9 |
|
44.11 |
mmHg |
3.23 |
9.68 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48041 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
8 |
|
5.12 |
mmHg |
0.36 |
1.01 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47205 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
6.11 |
ml/min/g |
1.45 |
4.35 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46209 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
60.02 |
% |
6.32 |
18.97 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46074 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
64.56 |
% |
4.81 |
14.42 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46076 |
461 |
FHH-Chr 18BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
10 |
|
42.6 |
mmHg |
5.84 |
18.46 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48043 |
461 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
49.66 |
mmHg |
1.67 |
4.72 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20491 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
27.96 |
ml/min |
3.12 |
10.35 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20218 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
58.21 |
ml/min |
6.93 |
18.33 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14508 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
0.24 |
ml |
0.02 |
0.06 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17990 |
381 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
male |
82 days-99 days |
8 |
|
32.34 |
mmHg |
0.71 |
2.0 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17256 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
0.26 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13931 |
381 |
FHH-Chr 18BN/Mcwi |
serum calcium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77 days-91 days |
10 |
|
9.43 |
mg/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36634 |
401 |
FHH-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
1.07 |
ml/min |
0.15 |
0.39 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52356 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
256.24 |
beats/min |
11.52 |
36.43 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48207 |
461 |
FHH-Chr 18BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
0.36 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17380 |
381 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
10 |
|
0.4 |
IU/g |
0.07 |
0.21 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47338 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
47.39 |
mmHg |
4.75 |
14.25 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45278 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
5 |
|
28.17 |
IU/g |
2.11 |
4.72 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45986 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
7 |
|
23.98 |
IU/g |
2.79 |
7.39 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45988 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
101.37 |
mmHg |
6.98 |
20.95 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44823 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
118.02 |
% |
6.61 |
19.82 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44926 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.49 |
null |
0.02 |
0.06 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58123 |
526 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77 days-91 days |
10 |
|
0.23 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39586 |
401 |
FHH-Chr 18BN/Mcwi |
body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
37.06 |
degrees C |
0.2 |
0.6 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16580 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
169.8 |
g |
4.1 |
12.9 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58378 |
526 |
FHH-Chr 18BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
9 |
|
12.45 |
% |
3.33 |
9.98 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49404 |
461 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin concentration |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
31.92 |
g/dl |
0.12 |
0.36 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39787 |
401 |
FHH-Chr 18BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
9 |
|
17.78 |
mmol/l |
0.66 |
1.99 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43168 |
401 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
-7.83 |
null |
0.18 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56136 |
522 |
FHH-Chr 18BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49 days-63 days |
9 |
|
12.95 |
% |
4.63 |
13.9 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49708 |
461 |
FHH-Chr 18BN/Mcwi |
heart wet weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
0.82 |
g |
0.06 |
0.19 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45415 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
2 |
|
106.35 |
mmHg |
5.35 |
7.57 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45512 |
461 |
FHH-Chr 18BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
10 |
|
55.4 |
fl |
0.31 |
0.97 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38687 |
401 |
FHH-Chr 18BN/Mcwi |
serum total bilirubin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
10 |
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41876 |
401 |
FHH-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
7.86 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42009 |
401 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
122.97 |
mmHg |
2.67 |
7.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48632 |
461 |
FHH-Chr 18BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49 days-63 days |
9 |
|
39.33 |
mmHg |
2.23 |
6.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50007 |
461 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
|
246.83 |
beats/min |
12.12 |
36.37 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47592 |
461 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
female |
77 days-91 days |
10 |
|
136.5 |
g |
3.2 |
10.1 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59072 |
526 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
20.88 |
ml/min/kg |
1.75 |
4.96 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58660 |
526 |
FHH-Chr 18BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
9 |
|
1.94 |
mg/kg |
0.38 |
1.14 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59204 |
526 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
83.12 |
% |
5.23 |
13.83 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48766 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
6 |
|
0.45 |
null |
0.02 |
0.04 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59812 |
526 |
FHH-Chr 18BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
49.08 |
% |
0.91 |
2.87 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39001 |
401 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
25.73 |
IU/g |
1.59 |
4.76 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48883 |
461 |
FHH-Chr 18BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
10 |
|
7.45 |
mg/dl |
0.24 |
0.76 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37867 |
401 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
30.02 |
ml/min/kg |
1.35 |
4.26 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57810 |
526 |
FHH-Chr 18BN/Mcwi |
serum potassium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
10 |
|
4.17 |
mmol/l |
0.17 |
0.54 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38076 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
158.06 |
% |
11.7 |
30.97 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54094 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82 days-99 days |
12 |
|
171.2 |
g |
3.0 |
10.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Dyets |
17827 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
0.25 |
ml |
0.01 |
0.04 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15241 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
-0.46 |
degrees C |
0.22 |
0.62 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15677 |
381 |
FHH-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
8 |
|
1.02 |
ml/min |
0.14 |
0.41 |
urine creatinine analysis |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52359 |
482 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
8 |
|
162.82 |
mmHg |
9.3 |
26.3 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52551 |
482 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
6 |
|
119.71 |
mmHg |
3.16 |
7.73 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13503 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
104.39 |
% |
3.28 |
10.86 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53898 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
105.57 |
% |
5.74 |
19.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53999 |
381 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
6 |
|
124.11 |
mmHg |
2.15 |
5.27 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19884 |
381 |
FHH-Chr 18BN/Mcwi |
serum calcium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
10 |
|
9.48 |
mg/dl |
0.14 |
0.43 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36632 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
31.72 |
g/dl |
0.14 |
0.43 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37368 |
401 |
FHH-Chr 18BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
9 |
|
864.67 |
s |
36.4 |
109.2 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49307 |
461 |
FHH-Chr 18BN/Mcwi |
serum chloride level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
10 |
|
108.6 |
mmol/l |
0.4 |
1.26 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39127 |
401 |
FHH-Chr 18BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77 days-91 days |
9 |
|
0.83 |
x 1000 cells/ul |
0.11 |
0.32 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38933 |
401 |
FHH-Chr 18BN/Mcwi |
serum bicarbonate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
10 |
|
21.1 |
mmol/l |
0.95 |
3.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42070 |
401 |
FHH-Chr 18BN/Mcwi |
serum bicarbonate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77 days-91 days |
10 |
|
21.8 |
mmol/l |
1.31 |
4.13 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42072 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
10 |
|
18.32 |
pg |
0.13 |
0.41 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42553 |
401 |
FHH-Chr 18BN/Mcwi |
red blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
10 |
|
9.19 |
x 10E6 cells/ul |
0.15 |
0.48 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39245 |
401 |
FHH-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
10 |
|
93.7 |
U/l |
3.95 |
12.49 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42778 |
401 |
FHH-Chr 18BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77 days-91 days |
9 |
|
26.11 |
mmol/l |
0.87 |
2.62 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43027 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
145.23 |
% |
8.45 |
23.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54438 |
381 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
9 |
|
17.29 |
pg |
0.11 |
0.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40235 |
401 |
FHH-Chr 18BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77 days-91 days |
8 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59395 |
526 |
FHH-Chr 18BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
9 |
|
0.05 |
x 1000 cells/ul |
0.03 |
0.08 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41441 |
401 |
FHH-Chr 18BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77 days-91 days |
9 |
|
14.67 |
mg/dl |
0.9 |
2.69 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41789 |
401 |
FHH-Chr 18BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
10 |
|
13.6 |
mg/dl |
0.48 |
1.51 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41792 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
41.06 |
% |
5.71 |
15.11 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48537 |
461 |
FHH-Chr 18BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
1133.44 |
s |
31.34 |
94.01 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46556 |
461 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
-8.1 |
null |
0.06 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55303 |
522 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
25.5 |
ml/min |
2.42 |
6.41 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16155 |
381 |
FHH-Chr 18BN/Mcwi |
FAPGG metabolism-surface area product |
controlled air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
62.96 |
ml/min/kg |
3.87 |
12.23 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58009 |
526 |
FHH-Chr 18BN/Mcwi |
body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
12 |
|
36.59 |
degrees C |
0.19 |
0.65 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16582 |
381 |
FHH-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77 days-91 days |
10 |
|
0.38 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58743 |
526 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
8 |
|
37.83 |
mmHg |
1.19 |
3.35 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16083 |
381 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
7 |
|
128.04 |
mmHg |
2.79 |
7.39 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45737 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
13.17 |
ml/min/g |
0.66 |
1.98 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46663 |
461 |
FHH-Chr 18BN/Mcwi |
heart weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
7.15 |
g/kg |
0.48 |
1.43 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45644 |
461 |
FHH-Chr 18BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
10 |
|
5.18 |
g/kg |
0.3 |
0.94 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47022 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
|
5.89 |
ml/min/g |
0.27 |
0.81 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46211 |
461 |
FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
10 |
|
400.95 |
beats/min |
13.32 |
42.11 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20940 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82 days-99 days |
8 |
|
-5.49 |
mmHg |
1.22 |
3.45 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19648 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
265.01 |
% |
27.16 |
76.82 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14208 |
381 |
FHH-Chr 18BN/Mcwi |
blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
8 |
|
7.47 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17067 |
381 |
FHH-Chr 18BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77 days-91 days |
9 |
|
143.11 |
mmol/l |
0.31 |
0.93 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36527 |
401 |
FHH-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
10 |
|
233.6 |
U/l |
10.77 |
34.07 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37490 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
51.44 |
% |
4.07 |
12.21 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47085 |
461 |
FHH-Chr 18BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
9 |
|
0.66 |
mEq/d |
0.11 |
0.33 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52312 |
482 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
182.05 |
mmHg |
4.28 |
12.83 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52548 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
264.24 |
beats/min |
8.38 |
25.13 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48205 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
3 |
post-ischemic value/pre-ischemic value x 100% |
51.93 |
% |
8.37 |
14.5 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46329 |
461 |
FHH-Chr 18BN/Mcwi |
heart weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49 days-63 days |
9 |
|
7.53 |
g/kg |
0.26 |
0.77 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45647 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
125.18 |
mmHg |
4.42 |
11.69 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45739 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
85.41 |
% |
3.93 |
11.8 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48414 |
461 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
10 |
|
137.4 |
g |
7.5 |
23.7 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47844 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
3 |
|
116.87 |
mmHg |
6.77 |
11.72 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46760 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
10 |
|
9.42 |
ml/min/g |
0.51 |
1.6 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46880 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
91.19 |
mmHg |
10.57 |
31.72 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44825 |
461 |
FHH-Chr 18BN/Mcwi |
serum glucose level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77 days-91 days |
10 |
|
145.1 |
mg/dl |
4.33 |
13.7 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38540 |
401 |
FHH-Chr 18BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77 days-91 days |
10 |
|
16.3 |
mmol/l |
0.67 |
2.11 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43171 |
401 |
FHH-Chr 18BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49 days-63 days |
9 |
|
11.06 |
% |
4.49 |
13.48 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49706 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
103.21 |
mmHg |
4.61 |
13.84 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49896 |
461 |
FHH-Chr 18BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
9 |
|
39.44 |
mmHg |
2.22 |
6.67 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50005 |
461 |
FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
9 |
|
14.0 |
g/dl |
0.47 |
1.4 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40139 |
401 |
FHH-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77 days-91 days |
10 |
|
4.2 |
mmol/l |
0.08 |
0.26 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43367 |
401 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
female |
49 days-63 days |
10 |
|
109.7 |
g |
7.8 |
24.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49549 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.15 |
IU/g |
0.06 |
0.17 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47471 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
83.52 |
% |
1.7 |
4.51 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48764 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
17.41 |
ml/min/kg |
1.04 |
2.95 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57606 |
526 |
FHH-Chr 18BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77 days-91 days |
9 |
|
64.0 |
U/l |
3.73 |
11.2 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37744 |
401 |
FHH-Chr 18BN/Mcwi |
absolute change in body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82 days-99 days |
8 |
|
-0.3 |
degrees C |
0.17 |
0.47 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15679 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
6 |
|
409.46 |
beats/min |
15.5 |
37.97 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15946 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
0.24 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15243 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
5 |
|
383.94 |
beats/min |
22.36 |
50.01 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15943 |
381 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
126.74 |
mmHg |
3.35 |
9.48 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15108 |
381 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
8 |
|
0.35 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52263 |
482 |
FHH-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
9 |
|
8.89 |
mEq/d |
1.85 |
5.54 |
flame atomic emission spectrometry |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52800 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82 days-99 days |
6 |
|
398.65 |
beats/min |
21.36 |
52.33 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14716 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
7 |
|
108.08 |
breaths/min |
7.72 |
20.44 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14943 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
8 |
|
83.06 |
breaths/min |
2.11 |
5.98 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14945 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
11 |
|
121.71 |
breaths/min |
9.21 |
30.55 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14804 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
8 |
|
180.56 |
% |
12.46 |
35.24 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54232 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
7 |
|
149.85 |
breaths/min |
6.43 |
17.01 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
17119 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
56.18 |
ml/min |
5.18 |
13.7 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20769 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
8 |
|
0.05 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19803 |
381 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
5 |
|
128.88 |
mmHg |
5.13 |
11.48 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19881 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
11 |
|
96.12 |
breaths/min |
4.52 |
14.99 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18420 |
381 |
FHH-Chr 18BN/Mcwi |
serum alkaline phosphatase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77 days-91 days |
10 |
|
333.1 |
U/l |
12.96 |
41.0 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36389 |
401 |
FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
37.01 |
degrees C |
0.25 |
0.69 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19077 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
138.41 |
% |
16.75 |
47.38 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18551 |
381 |
FHH-Chr 18BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
9 |
|
5.39 |
g/dl |
0.08 |
0.25 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37235 |
401 |
FHH-Chr 18BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77 days-91 days |
9 |
|
10.32 |
mg/dl |
0.14 |
0.42 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36796 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
233.01 |
% |
27.22 |
72.02 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19219 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
27.76 |
ml/min |
1.78 |
5.89 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18672 |
381 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
8 |
|
5.19 |
mmHg |
0.36 |
1.03 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49187 |
461 |
FHH-Chr 18BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
10 |
|
0.87 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49068 |
461 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
30.82 |
ml/min |
1.33 |
3.77 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20216 |
381 |
FHH-Chr 18BN/Mcwi |
absolute change in partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
8 |
|
-44.32 |
mmHg |
1.81 |
5.13 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
19482 |
381 |
FHH-Chr 18BN/Mcwi |
serum albumin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
10 |
|
3.73 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42243 |
401 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
9 |
|
0.22 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42683 |
401 |
FHH-Chr 18BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
9 |
|
5.64 |
x 1000 cells/ul |
0.85 |
2.55 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39922 |
401 |
FHH-Chr 18BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77 days-91 days |
9 |
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42920 |
401 |
FHH-Chr 18BN/Mcwi |
plasma creatinine level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77 days-91 days |
10 |
|
0.25 |
mg/dl |
0.02 |
0.05 |
automated plasma creatinine analysis |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39584 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin concentration |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
10 |
|
31.84 |
g/dl |
0.1 |
0.33 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39785 |
401 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
10 |
|
161.4 |
g |
6.8 |
21.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59070 |
526 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
17.55 |
pg |
0.08 |
0.26 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40238 |
401 |
FHH-Chr 18BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77 days-91 days |
9 |
|
4.52 |
mmol/l |
0.1 |
0.3 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43364 |
401 |
FHH-Chr 18BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
9 |
|
1.32 |
mg/kg |
0.19 |
0.56 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58914 |
526 |
FHH-Chr 18BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77 days-91 days |
10 |
|
0.12 |
x 1000 cells/ul |
0.04 |
0.12 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40334 |
401 |
FHH-Chr 18BN/Mcwi |
serum globulin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
10 |
|
1.46 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40558 |
401 |
FHH-Chr 18BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77 days-91 days |
8 |
|
140.25 |
mg/dl |
3.63 |
10.28 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41231 |
401 |
FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
9 |
|
43.63 |
% |
1.53 |
4.58 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41339 |
401 |
FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
43.53 |
% |
0.56 |
1.77 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41342 |
401 |
FHH-Chr 18BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
0.15 |
mmHg x min x kg x ml-1 |
0.01 |
0.03 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59555 |
526 |
FHH-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77 days-91 days |
10 |
|
1.54 |
g/dl |
0.03 |
0.11 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41067 |
401 |
FHH-Chr 18BN/Mcwi |
total white blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77 days-91 days |
10 |
|
8.22 |
x 1000 cells/ul |
0.65 |
2.06 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40934 |
401 |
FHH-Chr 18BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
10 |
|
1119.6 |
s |
39.72 |
125.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46558 |
461 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
18.79 |
ml/min/kg |
1.01 |
3.2 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57608 |
526 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
-6.83 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55653 |
522 |
FHH-Chr 18BN/Mcwi |
tidal volume |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
|
0.37 |
ml |
0.04 |
0.1 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16481 |
381 |
FHH-Chr 18BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
9 |
|
36.6 |
degrees C |
0.17 |
0.5 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16820 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77 days-91 days |
9 |
|
212.0 |
g |
6.8 |
20.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58375 |
526 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
24.23 |
ml/min |
2.54 |
7.17 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16698 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
21.95 |
ml/min |
0.91 |
3.02 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16700 |
381 |
FHH-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
0.0 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54705 |
522 |
FHH-Chr 18BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
1.43 |
E-7mole |
0.36 |
1.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
56551 |
522 |
FHH-Chr 18BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77 days-91 days |
10 |
|
0.09 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59928 |
526 |
FHH-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
73.89 |
% |
8.2 |
24.61 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57252 |
522 |
FHH-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
69.56 |
% |
4.56 |
13.68 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57255 |
522 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
52.71 |
mmHg |
5.36 |
16.08 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47921 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
7.21 |
ml/min/g |
0.71 |
2.14 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44726 |
461 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
|
8.26 |
ml/min/g |
0.51 |
1.45 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46878 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
89.29 |
% |
4.55 |
13.64 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48305 |
461 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
|
54.58 |
ml/min |
5.14 |
14.54 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20771 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
8 |
|
144.33 |
breaths/min |
8.28 |
23.42 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
16921 |
381 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82 days-99 days |
8 |
|
123.08 |
mmHg |
3.41 |
9.63 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14346 |
381 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82 days-99 days |
8 |
|
92.74 |
mmHg |
2.43 |
6.88 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18883 |
381 |
FHH-Chr 18BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
31.95 |
ml/min |
2.4 |
6.79 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18670 |
381 |
FHH-Chr 18BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
|
0.23 |
ml |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13933 |
381 |
FHH-Chr 18BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
9 |
|
79.22 |
mg/d |
28.78 |
86.34 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52403 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
442.33 |
beats/min |
16.64 |
49.92 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52501 |
482 |
FHH-Chr 18BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
80.53 |
% |
2.64 |
7.92 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48416 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
2 |
|
100.75 |
mmHg |
5.25 |
7.42 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
|
46758 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
38.48 |
mmHg |
7.46 |
22.37 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47711 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
97.04 |
% |
11.86 |
35.59 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
44928 |
461 |
FHH-Chr 18BN/Mcwi |
blood eosinophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77 days-91 days |
10 |
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41657 |
401 |
FHH-Chr 18BN/Mcwi |
blood neutrophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77 days-91 days |
10 |
|
0.87 |
x 1000 cells/ul |
0.21 |
0.66 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
43234 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
9 |
|
53.88 |
fl |
0.41 |
1.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38684 |
401 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
100.96 |
mmHg |
4.91 |
14.72 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49898 |
461 |
FHH-Chr 18BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77 days-91 days |
9 |
|
1.31 |
mg/kg |
0.29 |
0.86 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58916 |
526 |
FHH-Chr 18BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77 days-91 days |
10 |
|
103.4 |
mmol/l |
0.27 |
0.84 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40046 |
401 |
FHH-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
0.03 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54937 |
522 |
FHH-Chr 18BN/Mcwi |
serum alanine aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77 days-91 days |
10 |
|
56.8 |
U/l |
2.26 |
7.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40724 |
401 |
FHH-Chr 18BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
1.12 |
g/mg |
0.1 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57362 |
522 |
FHH-Chr 18BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
43.53 |
% |
0.56 |
1.77 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57527 |
526 |
FHH-Chr 18BN/Mcwi |
serum phosphate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77 days-91 days |
10 |
|
8.48 |
mg/dl |
0.18 |
0.57 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37604 |
401 |
FHH-Chr 18BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
49.08 |
% |
0.91 |
2.87 |
microhematocrit tube assay with visual assessment |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59267 |
526 |
FHH-Chr 18BN/Mcwi |
serum urea nitrogen level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77 days-91 days |
10 |
|
21.2 |
mg/dl |
1.11 |
3.52 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40838 |
401 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
10 |
|
126.2 |
mmHg |
2.82 |
8.92 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
15111 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
5 |
|
334.68 |
beats/min |
15.4 |
34.43 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14713 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
137.99 |
% |
11.08 |
31.33 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13688 |
381 |
FHH-Chr 18BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
8 |
|
125.9 |
breaths/min |
8.59 |
24.3 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14802 |
381 |
FHH-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
4.81 |
ng/ml/h |
0.78 |
2.07 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52895 |
482 |
FHH-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
8 |
|
10.07 |
ng/ml/h |
1.37 |
3.87 |
radioimmunoassay |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52898 |
482 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
7 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
223.0 |
% |
14.44 |
38.21 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14206 |
381 |
FHH-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82 days-99 days |
10 |
|
127.52 |
mmHg |
2.78 |
8.79 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
14349 |
381 |
FHH-Chr 18BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82 days-99 days |
8 |
|
373.53 |
beats/min |
10.07 |
28.47 |
vascular fluid filled catheter |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20937 |
381 |
FHH-Chr 18BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82 days-99 days |
8 |
|
7.42 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20642 |
381 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
8 |
|
95.9 |
mmHg |
2.27 |
6.42 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
18886 |
381 |
FHH-Chr 18BN/Mcwi |
serum total protein level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77 days-91 days |
10 |
|
5.28 |
g/dl |
0.08 |
0.27 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36970 |
401 |
FHH-Chr 18BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
10 |
|
3.56 |
x 1000 cells/ul |
0.33 |
1.04 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
36909 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77 days-91 days |
9 |
|
32.09 |
g/dl |
0.1 |
0.3 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37365 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
8 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
258.09 |
% |
16.95 |
47.94 |
stop flow air displacement plethysmography |
0 |
0 |
|
|
Moms and pups used in studies were fed Teklad |
19221 |
381 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
male |
49 days-63 days |
10 |
|
117.8 |
g |
5.4 |
17.0 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
49546 |
461 |
FHH-Chr 18BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49 days-63 days |
9 |
|
943.33 |
s |
38.3 |
114.9 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
50127 |
461 |
FHH-Chr 18BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
10 |
|
52.82 |
% |
0.71 |
2.24 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38999 |
401 |
FHH-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77 days-91 days |
9 |
|
91.89 |
U/l |
5.4 |
16.21 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42454 |
401 |
FHH-Chr 18BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77 days-91 days |
9 |
|
95.89 |
U/l |
6.08 |
18.24 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42457 |
401 |
FHH-Chr 18BN/Mcwi |
serum chloride level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77 days-91 days |
10 |
|
109.0 |
mmol/l |
0.56 |
1.76 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39125 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular volume |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77 days-91 days |
10 |
|
57.49 |
fl |
0.44 |
1.39 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38753 |
401 |
FHH-Chr 18BN/Mcwi |
mean corpuscular volume |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77 days-91 days |
10 |
|
58.85 |
fl |
0.29 |
0.93 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38755 |
401 |
FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
13.81 |
g/dl |
0.16 |
0.51 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40142 |
401 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82 days-99 days |
7 |
|
148.03 |
% |
14.26 |
37.74 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53643 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in respiration rate |
air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82 days-99 days |
8 |
|
174.55 |
% |
11.06 |
31.27 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53647 |
381 |
FHH-Chr 18BN/Mcwi |
serum phosphate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77 days-91 days |
10 |
|
8.04 |
mg/dl |
0.22 |
0.69 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37602 |
401 |
FHH-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
9 |
|
1.07 |
g/kg |
0.08 |
0.25 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59491 |
526 |
FHH-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77 days-91 days |
10 |
|
1.56 |
g/kg |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59665 |
526 |
FHH-Chr 18BN/Mcwi |
lung dry weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77 days-91 days |
10 |
|
1.71 |
g/kg |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59667 |
526 |
FHH-Chr 18BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77 days-91 days |
9 |
|
1.57 |
g/dl |
0.03 |
0.1 |
standard blood chemistry panel |
|
0 |
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41064 |
401 |
FHH-Chr 18BN/Mcwi |
blood hemoglobin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77 days-91 days |
10 |
|
15.67 |
g/dl |
0.28 |
0.89 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
37978 |
401 |
FHH-Chr 18BN/Mcwi |
blood eosinophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77 days-91 days |
10 |
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41655 |
401 |
FHH-Chr 18BN/Mcwi |
plasma anion gap |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77 days-91 days |
10 |
|
18.2 |
mmol/l |
0.7 |
2.2 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
38269 |
401 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
9 |
|
52.3 |
mmHg |
3.71 |
11.13 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46427 |
461 |
FHH-Chr 18BN/Mcwi |
heart wet weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49 days-63 days |
9 |
|
0.84 |
g |
0.07 |
0.21 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45413 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
0.21 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47474 |
461 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
250.0 |
g |
3.9 |
12.2 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55208 |
522 |
FHH-Chr 18BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
174.3 |
g |
2.1 |
6.5 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55210 |
522 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
224.7 |
beats/min |
10.33 |
30.98 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48953 |
461 |
FHH-Chr 18BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
-6.92 |
null |
0.04 |
0.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55656 |
522 |
FHH-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
8 |
|
0.22 |
null |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
57938 |
526 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
172.1 |
g |
2.3 |
7.4 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55445 |
522 |
FHH-Chr 18BN/Mcwi |
FAPGG metabolism-surface area product |
controlled air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
59.72 |
ml/min/kg |
2.38 |
6.73 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58007 |
526 |
FHH-Chr 18BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
6 |
|
44.45 |
ml/min/kg |
3.76 |
9.21 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58263 |
526 |
FHH-Chr 18BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77 days-91 days |
10 |
|
0.03 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58499 |
526 |
FHH-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
83.0 |
% |
6.92 |
20.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54811 |
522 |
FHH-Chr 18BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77 days-91 days |
10 |
|
0.38 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
58741 |
526 |
FHH-Chr 18BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77 days-91 days |
8 |
|
12.0 |
ml/min/kg |
0.97 |
2.74 |
isolated perfused lung vascular effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
60031 |
526 |
FHH-Chr 18BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
9 |
|
14.1 |
ml/min/g |
0.81 |
2.43 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
46661 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49 days-63 days |
9 |
|
0.43 |
IU/g |
0.03 |
0.1 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47335 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
102.42 |
% |
24.44 |
73.31 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48303 |
461 |
FHH-Chr 18BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
8 |
|
112.63 |
% |
5.52 |
15.61 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
53894 |
381 |
FHH-Chr 18BN/Mcwi |
partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82 days-99 days |
8 |
|
51.58 |
mmHg |
1.45 |
4.11 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
20494 |
381 |
FHH-Chr 18BN/Mcwi |
body temperature |
air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82 days-99 days |
8 |
|
36.55 |
degrees C |
0.13 |
0.37 |
digital rectal thermometry |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13567 |
381 |
FHH-Chr 18BN/Mcwi |
blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82 days-99 days |
8 |
|
7.49 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
0 |
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17064 |
381 |
FHH-Chr 18BN/Mcwi |
percent change in ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
11 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
127.89 |
% |
8.47 |
28.08 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
13690 |
381 |
FHH-Chr 18BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
|
0.9 |
mEq/d |
0.11 |
0.32 |
flame atomic emission spectrometry |
|
0 |
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52309 |
482 |
FHH-Chr 18BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
52.01 |
% |
4.08 |
12.25 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47087 |
461 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
8 |
|
415.13 |
beats/min |
8.11 |
22.93 |
vascular fluid filled catheter |
|
0 |
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52504 |
482 |
FHH-Chr 18BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49 days-63 days |
9 |
|
267.31 |
beats/min |
62.35 |
187.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45156 |
461 |
FHH-Chr 18BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49 days-63 days |
9 |
|
46.62 |
mmHg |
3.04 |
9.11 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
47709 |
461 |
FHH-Chr 18BN/Mcwi |
blood monocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77 days-91 days |
10 |
|
0.55 |
x 1000 cells/ul |
0.09 |
0.29 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39682 |
401 |
FHH-Chr 18BN/Mcwi |
blood lymphocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77 days-91 days |
10 |
|
5.13 |
x 1000 cells/ul |
0.4 |
1.25 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
41513 |
401 |
FHH-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54702 |
522 |
FHH-Chr 18BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77 days-91 days |
9 |
|
8.09 |
x 10E6 cells/ul |
0.22 |
0.66 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
42006 |
401 |
FHH-Chr 18BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77 days-91 days |
9 |
|
3.82 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40444 |
401 |
FHH-Chr 18BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77 days-91 days |
10 |
|
3.97 |
g/dl |
0.04 |
0.14 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
40447 |
401 |
FHH-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
0.04 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
54934 |
522 |
FHH-Chr 18BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
4 |
|
120.05 |
mmHg |
5.37 |
10.74 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
45514 |
461 |
FHH-Chr 18BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77 days-91 days |
8 |
|
2.1 |
mg/kg |
0.42 |
1.19 |
stop flow air displacement plethysmography |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
59201 |
526 |
FHH-Chr 18BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49 days-63 days |
7 |
|
120.42 |
mmHg |
4.11 |
10.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48634 |
461 |
FHH-Chr 18BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49 days-63 days |
9 |
|
25.4 |
IU/g |
2.75 |
8.26 |
isolated perfused heart effluent collection |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
48885 |
461 |
FHH-Chr 18BN/Mcwi |
red blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77 days-91 days |
10 |
|
8.34 |
x 10E6 cells/ul |
0.17 |
0.53 |
automated blood cell counting method |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39247 |
401 |
FHH-Chr 18BN/Mcwi |
serum sodium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77 days-91 days |
10 |
|
142.8 |
mmol/l |
0.79 |
2.49 |
standard blood chemistry panel |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
39398 |
401 |
FHH-Chr 18BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
230.5 |
g |
5.6 |
17.6 |
whole body digital scale |
|
0 |
|
|
Moms and pups used in studies were fed Teklad |
55442 |
522 |